This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Felix Schumacher
Program Leader Targeted Therapeutics at Roche
Speaker

Agenda Sessions

  • Beyond the Standard: Advancing TfR-Mediated Delivery of Oligonucleotide Therapeutics to the CNS

    , 10:45am
    View Session

At this event

Prev
Next
Kevin Seibert, PhD
Vice President, Engineering, Synthetic Molecule Design and Development
Eli Lilly and Company

See Felix at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now